On July 24, 2017, a Chicago jury found in favor of claimant Jesse Mitchell in the second, much-anticipated AndroGel bellwether trial that started on July 5 in the testosterone replacement therapy (TRT) multidistrict litigation in the U.S. District Court for the Northern District of Illinois (Jesse Mitchell, et al. v. AbbVie, Inc., No. 14-9178, N.D....
$150 Million Punitive Damages Verdict in Testosterone Heart Attack Lawsuit for False Marketing
